DURECT Corporation DRRX today reported that King Pharmaceuticals, Inc. KG and Pain Therapeutics, Inc. PTIE have announced that King has resubmitted a New Drug Application for REMOXY to the U.S. Food and Drug Administration in response to a Complete Response Letter received by Pain Therapeutics in December 2008.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
